Th2-associated local reactions to the acellular diphtheria-tetanus- pertussis vaccine in 4- to 6-year-old children

Infection and Immunity

Volumn 73, Issue 12, 2005, Pages 8130-8135

  Rowe, Julie ^a   Yerkovich, Stephanie T ^a   Richmond, Peter ^b   Suriyaarachchi, Devinda ^a   Fisher, Elizabeth ^c   Feddema, Leonie ^c   Loh, Richard ^c   Sly, Peter D ^a   Holt, Patrick G ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACELLULAR VACCINE; CYTOKINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; INTERLEUKIN 6; IPOL; MEASLES MUMPS RUBELLA VACCINE;

ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CHILDHOOD DISEASE; CYTOKINE PRODUCTION; DIPHTHERIA; DISEASE COURSE; DRUG SAFETY; HELPER CELL; HUMAN; HUMAN EXPERIMENT; IMMUNOLOGICAL MEMORY; INJECTION SITE REACTION; NORMAL HUMAN; PERTUSSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; REGULATORY MECHANISM; TETANUS; TH2 CELL; VACCINE PRODUCTION;

ANTIBODY FORMATION; CHILD; CHILD, PRESCHOOL; CYTOKINES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; INTERLEUKINS; TH2 CELLS; VACCINES, ACELLULAR;

EID: 28444461797     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.12.8130-8135.2005     Document Type: Article

References (31)

1. Adkins, B., and R.-Q. Du. 1998. Newborn mice develop balanced Th1/Th2 primary effector responses in vivo but are biased to Th2 secondary responses. J. Immunol. 160:4217-4224.
2. Aggerbeck, H., J. Wantzin, and I. Heron. 1996. Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations-III. Vaccine 74:1265-1272.
3. Anonymous. 1998. WHO meeting on maternal and neonatal pneumococcal immunization. Wkly. Epidemiol. Rec. 25:187-188.
4. Ausiello, C. M., F. Urbani, A. La Sala, R. Lande, and A. Cassone. 1997. Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect. Immun. 65:2168-2174.
5. Barrios, C., P. Brawand, M. Berney, C. Brandt, P.-H. Lambert, and C.-A. Siegrist. 1996. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur. J. Immunol. 26:1489-1496.
6. Edwards, K. M., M. D. Decker, M. C. Steinhoff, M. B. Rennels, M. E. Pichichero, J. A. Englund, E. L. Anderson, M. A. Deloria, G. F. Reed, and The NIAID Acellular Pertussis Vaccine Study Group. 1993. Comparison of 13 acellular pertussis vaccines: adverse reactions. Biologicals 21:8.
7. Greco, D., S. Salmaso, P. Mastrantonio, M., Giuliano, A. Tozzi, A. Anemona, M. L. Ciofo degli Atti, A. Giammanco, P. Panel, W. C. Black-welder, D. L. Klein, and S. G. F. Wassilak for The Progetto Pertosse Working Group. 1996. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N. Engl. J. Med. 334:341-348.
8. Harris, G., T. Nolan, and L. Hartman. 1995. Clinical signs associated with Triple Antigen (DTP) vaccination in infants. J. Pediatr. Child Health 31:228-232.
9. Heaton, T., J. Rowe, S. Turner, R. C. Aalberse, N. de Klerk, D. Suriyaarachchi, M. Serralha, B. J. Holt, E. Hollams, S. Yerkovich, K. Holt, P. D. Sly, J. Goldblatt, P. N. Le Souef, and P. G. Holt. 2005. An immunoepidemiological approach to asthma: identification of in-vitro T-cell response patterns associated with different wheezing phenotypes in children. Lancet 365:142-149.
10. Holt, P. G., and J. Rowe. 2003. The developing immune system and allergy, p. 69-79. In D. Y. M. Leung, H. A. Sampson, R. S. Geha, and S. J. Szefler (ed.), Pediatric allergy: principles and practice. Mosby, St. Louis, Mo.
11. Kurikka, S., H. Kayhty, H. Peltola, L. Saarinen, J. Eskola, and P. H. Makela. 1995. Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. Pediatrics 95:815-822.
12. Lau, G. C., A. Dannemann, C. Sommerfeld, U. Wahn, and R. C. Aalberse. 2001. Down-regulation of IgE and IgG4 antibodies to tetanus toxoid and diphtheria toxoid by covaccination with cellular Bordetella pertussis vaccine. J. Immunol. 167:2411-2417.
13. Long, S. S., A. DeForest, D. G. Smith, C. Lazaro, and G. F. Wassilak. 1990. Longitudinal study of adverse reactions following diphtheria-tetanus- pertussis vaccine in infancy. Pediatrics 85:294-302.
14. Meriste, S., E. Yamm, P. Willems, and I. Lutsar. 1999. Safety and immunogenicity of combined DTPa-IPV vaccine for primary and booster vaccination. Scand. J. Infect. Dis. 31:587-591.
15. O'Garra, A., and N. Arai. 2000. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol. 10:542-550.
16. Olin, P., F. Rasmussen, L. Gustafsson, H. O. Hallander, H. Heijbel, and Ad Hoc Group for the Study of Pertussis Vaccines. 1997. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Lancet 350:1569-1577.
17. Orsolini, P., C. Belloni, C. Klersy, D. Campisi, G. Chirico, C. Togni, U. Maccarini, F. Polatti, M. Martinetti, L. Salvaneschi, C. Zarall, G. Rondini, and G. Filice. 1995. Anti-HBV neonatal immunization with recombinant vaccine. Part I. Critical appraisal for a long-lived antibody course. Vaccine 13:551-554.
18. Prescott, S. L., C. Macaubas, T. Smallacombe, B. J. Holt, P. D. Sly, and P. G. Holt. 1999. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 353:196-200.
19. Rennels, M. B. 2003. Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines. Semin. Pediatr. Infect. Dis. 14:196-198.
20. Rennels, M. B., M. A. Deloria, M. E. Pichichero, G. A. Losonsky, J. A. Englund, B. D. Meade, E. L. Anderson, M. C. Steinhoff, and K. M. Edwards. 2000. Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines. Pediatrics 105:e12.
21. + T cells and early sensitization among infants at high risk of atopy. J. Allergy Clin. Immunol. 113:710-716.
22. Rowe, J., C. Macaubas, T. Monger, B. J. Holt, J. Harvey, J. T. Poolman, R. Loh, P. D. Sly, and P. G. Holt. 2001. Heterogeneity in diphtheria-tetanus- acellular pertussis vaccine-specific cellular immunity during infancy: relationship to variations in the kinetics of postnatal maturation of systemic Th1 function. J. Infect. Dis. 184:80-88.
23. Rowe, J., C. Macaubas, T. Monger, B. J. Holt, J. Harvey, J. T. Poolman, P. D. Sly, and P. G. Holt. 2000. Antigen-specific responses to diphtheria-tetanus-acellular pertussis vaccine in human infants are initially Th2 polarized. Infect. Immun. 68:3873-3877.
24. 23a. Rowe, J., J. T. Poolman, C. Macaubas, P. D. Sly, R. Loh, and P. G. Holt. 2004. Enhancement of vaccine-specific cellular immunity in infants by passively acquired maternal antibody. Vaccine 22:3986-3992.
25. Ryan, E. J., L. Nilsson, N.-I. M. Kjellman, L. Gothefors, and K. H. G. Mills. 2000. Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens. Clin. Exp. Immunol. 121:193-200.
26. Ryan, M., G. Murphy, E. Ryan, L. Nilsson, F. Shackley, L. Gothefors, K. Øymar, E. Miller, J. Storsaeter, and K. H. G. Mills. 1998. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 93:1-10.
27. Scheitele, D. W., S. A. Halperin, and A. C. Ferguson. 2001. Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigens. Vaccine 19:4720-4726.
28. Scheifele, D. W., W. Meekison, M. Grace, L. Barreto, A. O. Carter, L. Mitchell, and J. Farley. 1991. Adverse reactions to the preschool (fifth) dose of adsorbed diphtheria-pertussis-tetanus vaccine in Canadian children. Can. Med. Assoc. J. 145:641-647.
29. Tozzi, A. E., A. Anemona, P. Stefanelli, S. Salmaso, M. L. Atti, P. Mastrantonio, A. Giammanco, and the Progetto Pertosse Working Group. 2001. Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in infancy with acellular vaccines. Pediatrics 107:E25.
30. Vandelaer, J., M. Birmingham, F. Gasse, M. Kurian, C. Shaw, and S. Garnier. 2003. Tetanus in developing countries: an update on the Maternal and Neonatal Tetanus Elimination Initiative. Vaccine 21:3442-3445.
31. Vekemans, J., M. O. C. Ota, E. C. V. Wang, M. Kidd, L. K. Borysiewicz, H. Whittle, K. P. W. J. McAdam, G. Morgan, and A. Marchant. 2002. T cell responses to vaccines in infants: defective IFNγ production after oral polio vaccination. Clin. Exp. Immunol. 127:495-498.